Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype

This study supports a positive benefit-risk profile for long-term mepolizumab treatment in these patients.

Source: Journal of Allergy and Clinical Immunology - August 15, 2019 Category: Allergy & Immunology Authors: Atul Gupta, Masanori Ikeda, Bob Geng, Jay Azmi, Robert G. Price, Eric S. Bradford, Steven W. Yancey, Jonathan Steinfeld Source Type: research